Tags |
|
|
Links |
|
|
Main Subject - Whois Data Base Closures Hurt Consumers Say FTC
The Federal Trade Commission realizes that the Whois Data Base
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
information can be hidden from view for only $9.00 per year for
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
domain name owners. Many scam website frauds can therefore hide
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
for weeks until a court order is issued to turn over that info
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
mation. This helps Spammers, Phishers and Identity Thieves pull
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
scams.
But critics say that if people allow their listing the
But critics say that if people allow their listing the
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
they get bombarded with Spam too. Spammers scour the Whois dat
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
abases and collect email addresses to Spam us all with. So it i
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
a Catch 22 in that the FTC needs to get to these Spammers webs
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ites and find out who-is-who, but privacy people say they are n
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
t happy with the Federal Trade Commissions request and cite tha
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
t the FTC has been unable to stop Spam anyway.
Therefore why i
Therefore why i
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
the FTC violating privacy rights, when they are suppose to sto
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
p Spam, which has gone up some 3000% since the Federal Trade Co
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
mission started to attempt to go after all the Spammers?
Meanw
Meanw
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
hile, now there is a legal battle brewing and the FTC is lookin
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
rather incompetent these days as they had two-lap tops stolen
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
in Scottsdale AZ with 110 personal identification information o
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
of employees? Ouch? So is the FTC on its last leg these days o
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
r what? Dah? Talk about incompetence? Consider all this in 2006
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/59321/mainsubjects-Whois-Data-Base-Closures-Hurt-Consumers-Say-FTC.html">Whois Data Base Closures Hurt Consumers Say FTC</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/59321/mainsubjects-Whois-Data-Base-Closures-Hurt-Consumers-Say-FTC.html]Whois Data Base Closures Hurt Consumers Say FTC[/url]
Related Articles:
Does Customer Service Still Exist?
Are Salespeople Becoming Obsolete?
Bookmark it:
|